NewsBenzingaPharming conferma la guidance sulle vendite per l’esercizio 2026 di 380,000 milioni di dollari-390,000 milioni di dollari rispetto ai 383,333 milioni di dollari stimati Pharming conferma la guidance sulle vendite per l’esercizio 2026 di 380,000 milioni di dollari-390,000 milioni di dollari rispetto ai 383,333 milioni di dollari stimati Benzinga 2026.10.27 08:06 (GMT+0) Open on Benzinga Other news ChargePoint Unveils Channel Partner Program To Help European Resellers Capture Growing Demand For EV Charging Infrastructure Why Is Whirlpool Stock Falling Tuesday? Needham Maintains Buy on Applied Optoelectronics, Lowers Price Target to $170 CenterPoint Energy Q3 Adj. EPS $0.53 Beats $0.49 Estimate, Sales $2.191B Beat $2.173B Estimate Microsoft Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call TransUnion Raises Share Buyback Authorization By $1B To $2B Total
ChargePoint Unveils Channel Partner Program To Help European Resellers Capture Growing Demand For EV Charging Infrastructure
Microsoft Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
